Stocks · Health care · Pharmaceutical Preparations

NATURES SUNSHINE PRODUCTS INC

NATR Clue Score57
United States Fiscal year ends December CIK 0000275053 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Kevin R. Herbert
12 Jun 2026
EVP & President, North America
Sell
866
$20.75
$17.97K
Kevin R. Herbert
12 Jun 2026
EVP & President, North America
Sell
1,134
$20.63
$23.39K
Bryant J Yates
5 Jun 2026
EVP & President, Europe
Sell
11,968
$19.90
$238.16K
Daniel C Norman
1 Jun 2026
EVP & President, Asia
Sell
9,713
$20.64
$200.48K
Nathan G Brower
21 May 2026
EVP, General Counsel
Sell
12,015
$21.84
$262.41K
Jonathan David Lanoy
13 Mar 2026
SVP, Chief Accounting Officer
Sell
4,000
$24.70
$98.80K
Daniel C Norman
13 Mar 2026
EVP & President, Asia
Sell
15,383
$24.52
$377.19K
Bryant J Yates
13 Mar 2026
EVP & President, Europe
Sell
19,516
$24.35
$475.21K
Bryant J Yates
12 Dec 2025
EVP & President, Europe
Sell
1,700
$22.29
$37.89K
Jonathan David Lanoy
18 Nov 2025
SVP, Chief Accounting Officer
Sell
5,000
$20.45
$102.25K
Nathan G Brower
14 Nov 2025
EVP, General Counsel
Sell
3,800
$20.81
$79.08K
Daniel C Norman
12 Nov 2025
EVP & President, Asia
Sell
8,884
$20.46
$181.77K
Bryant J Yates
29 Aug 2025
EVP & President, Europe
Sell
4,672
$16.71
$78.07K
Bryant J Yates
26 Aug 2025
EVP & President, Europe
Sell
5,000
$16.77
$83.85K
Nathan G Brower
13 Aug 2025
EVP, General Counsel
Sell
9,996
$16.54
$165.33K
Jonathan David Lanoy
13 Aug 2025
SVP, Chief Accounting Officer
Sell
5,000
$16.51
$82.55K
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
27 Jun 2025
10% owner
Sell indirect
2,854,607
$11.46
$32.71M
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
15 Oct 2024
10% owner
Sell indirect
2,300
$13.02
$29.95K
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
14 Oct 2024
10% owner
Sell indirect
1,300
$13.12
$17.06K
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
11 Oct 2024
10% owner
Sell indirect
1,580
$13.37
$21.12K
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
10 Oct 2024
10% owner
Sell indirect
3,000
$13.39
$40.17K
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
9 Oct 2024
10% owner
Sell indirect
1,816
$13.36
$24.26K
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
8 Oct 2024
10% owner
Sell indirect
1,800
$13.13
$23.63K
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
1 Oct 2024
10% owner
Sell indirect
1,399
$13.54
$18.94K
Bryant J Yates
6 Jun 2024
EVP & President, Europe
Sell
3,068
$15.30
$46.94K
Daniel C Norman
30 Nov 2023
EVP & President, Asia
Sell
13,000
$17.06
$221.78K
Daniel C Norman
29 Nov 2023
EVP & President, Asia
Sell
2,000
$17.59
$35.18K
Nathan G Brower
21 Nov 2023
EVP, General Counsel
Sell
3,999
$17.31
$69.22K
Bryant J Yates
9 Jun 2023
EVP & President, Europe
Sell
1,767
$12.09
$21.36K
Bryant J Yates
8 Jun 2023
EVP & President, Europe
Sell
2,630
$12.00
$31.56K
Bryant J Yates
5 Jun 2023
EVP & President, Europe
Sell
1,315
$11.20
$14.73K
Daniel C Norman
2 Jun 2023
EVP & President, Asia
Sell
622
$11.14
$6.93K
Bryant J Yates
2 Jun 2023
EVP & President, Europe
Sell
618
$11.19
$6.92K
Daniel C Norman
1 Jun 2023
EVP & President, Asia
Sell
1,025
$11.29
$11.57K
Bryant J Yates
1 Jun 2023
EVP & President, Europe
Sell
1,638
$11.28
$18.48K
Daniel C Norman
25 May 2023
EVP & President, Asia
Sell
9,683
$11.19
$108.35K
Bryant J Yates
25 May 2023
EVP & President, Europe
Sell
1,500
$11.36
$17.04K
Daniel C Norman
24 May 2023
EVP & President, Asia
Sell
1,623
$11.12
$18.05K
Daniel C Norman
23 May 2023
EVP & President, Asia
Sell
2,311
$11.13
$25.72K
Daniel C Norman
22 May 2023
EVP & President, Asia
Sell
206
$11.12
$2.29K
Nathan G Brower
19 May 2023
EVP, General Counsel
Sell
3,128
$10.85
$33.94K
Nathan G Brower
18 May 2023
EVP, General Counsel
Sell
8,268
$11.01
$91.03K
Nathan G Brower
9 Dec 2022
EVP, General Counsel
Sell
4,972
$8.18
$40.67K
Prescott Group Capital Management, L.l.c.
4 Jun 2020
10% owner
Sell indirect
500,000
$9.50
$4.75M
Kristine F Hughes
11 Nov 2019
Director
Sell indirect
5,290
$9.21
$48.72K
Kristine F Hughes
1 May 2019
Director
Sell indirect
3,000
$8.84
$26.52K
Kristine F Hughes
3 Apr 2019
Director
Sell indirect
3,000
$9.41
$28.23K
Kristine F Hughes
6 Mar 2019
Director
Sell indirect
3,000
$7.93
$23.79K
Kristine F Hughes
6 Feb 2019
Director
Sell indirect
3,000
$7.96
$23.88K
Kristine F Hughes
2 Jan 2019
Director
Sell indirect
3,000
$7.72
$23.16K
Kristine F Hughes
5 Dec 2018
Director
Sell indirect
3,000
$9.01
$27.03K
Kristine F Hughes
6 Nov 2018
Director
Sell indirect
3,000
$9.23
$27.69K
Kristine F Hughes
3 Oct 2018
Director
Sell indirect
3,000
$8.67
$26.01K
Kristine F Hughes
4 Sep 2018
Director
Sell indirect
3,000
$9.00
$27.00K
Kristine F Hughes
1 Aug 2018
Director
Sell indirect
3,000
$7.57
$22.71K
Kristine F Hughes
5 Jul 2018
Director
Sell indirect
3,000
$9.16
$27.48K
Kristine F Hughes
6 Jun 2018
Director
Sell indirect
3,000
$8.73
$26.19K
Kristine F Hughes
9 May 2018
Director
Sell indirect
2,000
$9.83
$19.66K
Kristine F Hughes
4 Apr 2018
Director
Sell indirect
2,000
$9.91
$19.82K
Kristine F Hughes
7 Mar 2018
Director
Sell indirect
2,000
$11.16
$22.32K
Kristine F Hughes
7 Feb 2018
Director
Sell indirect
2,000
$11.33
$22.65K
Kristine F Hughes
10 Jan 2018
Director
Sell indirect
2,000
$11.56
$23.11K
Kristine F Hughes
6 Dec 2017
Director
Sell indirect
2,000
$12.06
$24.12K
Kristine F Hughes
8 Nov 2017
Director
Sell indirect
2,000
$8.97
$17.94K
Kristine F Hughes
4 Oct 2017
Director
Sell indirect
2,000
$10.48
$20.96K
Kristine F Hughes
6 Sep 2017
Director
Sell indirect
2,000
$10.04
$20.08K
Kristine F Hughes
9 Aug 2017
Director
Sell indirect
2,000
$10.44
$20.88K
Kristine F Hughes
5 Jul 2017
Director
Sell indirect
2,000
$13.16
$26.32K
Kristine F Hughes
12 Jun 2017
Director
Sell indirect
2,000
$13.82
$27.64K

What was left out

Form 4 filings counted 439
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 38
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 69
Transactions with no price 0
Shares from compensation/vesting 5,666,119
Sales filed before the plan box existed 27
History held since 11 Jan 2007